People given the experimental vaccine with standard treatment lived longer without their cancer returning, the companies reported this week.
Ed Cara is a writer at Gizmodo. He focuses on health and science journalism, exploring topics such as healthcare administration, public health, and the latest health advances, along with the occasional animal news. Ed has been featured in various outlets, including Yahoo News, Lifehacker Australia, and Quartz.
















